Okano M, Nomura M, Hata S, Okada N, Sato K, Kitano Y, Tashiro M, Yoshimoto Y, Hama R, Aoki T
Department of Dermatology, Osaka University School of Medicine, Japan.
Arch Dermatol. 1989 Jan;125(1):50-2.
Six patients who developed urticaria, dyspnea, and anaphylactic shock due to topical application of chlorhexidine gluconate solution are described. Chlorhexidine gluconate was confirmed as the causative agent of type I hypersensitivity by intradermal, scratch, and epicutaneous tests. To prevent life-threatening adverse reactions, it seems important to use chlorhexidine gluconate on wound surfaces at a concentration of 0.05%, as recommended by the manufacturer; chlorhexidine gluconate may not be suitable for application to mucous membranes.
本文描述了6例因局部应用葡萄糖酸氯己定溶液而出现荨麻疹、呼吸困难和过敏性休克的患者。通过皮内试验、划痕试验和表皮试验证实葡萄糖酸氯己定是Ⅰ型超敏反应的致病因素。为防止危及生命的不良反应,按照制造商的建议,以0.05%的浓度在伤口表面使用葡萄糖酸氯己定似乎很重要;葡萄糖酸氯己定可能不适用于黏膜。